Use of Nonprescription Dietary Supplements for Weight Loss Is Common among Americans

Journal of the American Dietetic Association

Volumn 107, Issue 3, 2007, Pages 441-447

  Blanck, Heidi Michels ^a   Serdula, Mary K ^a   Gillespie, Cathleen ^a   Galuska, Deborah A ^a   Sharpe, Patricia A ^a   Conway, Joan M ^a   Khan, Laura Kettel ^a   Ainsworth, Barbara E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHI SQUARE DISTRIBUTION; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; EVIDENCE BASED MEDICINE; FEMALE; HEALTH BEHAVIOR; HUMAN; MALE; MIDDLE AGED; NONPARAMETRIC TEST; OBESITY; RISK; SAFETY; SEX RATIO; STATISTICAL MODEL; STATISTICS; TIME; TREATMENT OUTCOME; UTILIZATION REVIEW; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTI-OBESITY AGENTS; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH BEHAVIOR; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; SAFETY; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

CITRUS AURANTIUM; EPHEDRA;

EID: 33847129551     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2006.12.009     Document Type: Article

References (34)

1. National Heart, Lung, and Blood Institute, and National Institute of Diabetes and Digestive and Kidney Diseases. Obesity education initiative. Clinical Guidelines on the Identification, Education, and Treatment of Overweight and Obesity in Adults: The Evidence Report (1998) NIH Publication No. 98-4083. Bethesda, MD
2. Saper R.B., Eisenberg D.M., and Phillips R.S. Common dietary supplements for weight loss. Am Fam Physician 70 (2004) 1731-1738
3. Weight-Loss Advertising: An Analysis of Current Trends, A Report of the Staff of the Federal Trade Commission, Conclusion, page 31. Available at: http://www.ftc.gov/bcp/reports/weightloss.pdf. Accessed May 22, 2006.
4. Ashar B.H., Miller R.G., Getz K.J., and Pichard C.P. A critical evaluation of Internet marketing of products that contain ephedra. Mayo Clin Proc 78 (2003) 944-946
5. Allison D.B., Fontaine K.R., Heshka S., Mentore J.L., and Heymsfield S.B. Alternative treatments for weight loss: A critical review. Crit Rev Food Sci Nutr 41 (2001) 1-28
6. Pittler M.H., and Ernst E. Dietary supplements for body-weight reduction: A systematic review. Am J Clin Nutr 79 (2004) 529-536
7. Lenz T.L., and Hamilton W.R. Supplemental products used for weight loss. J Am Pharm Assoc 44 (2004) 59-67
8. Dwyer J.T., Allison D.B., and Coates P.M. Dietary supplements in weight reduction. J Am Diet Assoc 105 suppl 1 (2005) S80-S86
9. Haaz S. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: An update. Obes Rev 7 (2006) 79-88
10. Shekelle P.G., Hardy M.L., Morton S.C., Maglione M., Mojica W.A., Suttorp M.J., Rhodes S.L., Jungvig L., and Gagne J. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: A meta-analysis. JAMA 289 (2003) 1537-1545
11. Fugh-Berman A. Herb-drug interactions. Lancet 355 (2000) 134-138
12. Gurley B.J., Gardner S.F., and Hubbard M.A. Content vs label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm 57 (2000) 963-969
13. Allison D.B., Cutter G., Poehlman E.T., Moore D.R., and Barnes S. Exactly which synephrine alkaloids does citrus aurantium (bitter orange) contain?. Int J Obes 29 (2005) 443-446
14. Robinson R.F., Griffith J.R., Nahata M.C., Mahan J.D., and Casavant M.J. Herbal weight-loss supplement misadventures per a regional poison center. Ann Pharmacother 38 (2004) 787-790
15. Basch E.M., Servoss J.C., and Tedrow U.B. Safety assurances for dietary supplements policy issues and new research paradigms. J Herb Pharmacother 5 (2005) 3-15
16. Radimer K., Bindewald B., Hughes J., Ervin B., Swanson C., and Picciano M.F. Dietary supplement use by US adults: Data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 160 (2004) 339-349
17. Blanck H.M., Khan L.K., and Serdula M.K. Use of nonprescription weight loss products: Results from a multistate survey. JAMA 286 (2001) 930-935
18. Mokdad A.H., Stroup D.F., and Giles W.H. Public health surveillance for behavioral risk factors in a changing environment: Recommendations from the Behavioral Risk Factor Surveillance Team. MMWR Recomm Rep 52 (2003) 1-9
19. Frankel L.R. The Report of the CASRO Task Force on Response Rates. In: Wiseman F. (Ed). Improving Data Quality in a Sample Survey (1983), Marketing Science Institute, Cambridge, MA
20. Macera C.A., Ham S.A., Yore M.M., Jones D.A., Ainsworth B.E., Kimsey C.D., and Kohl III H.W. Prevalence of physical activity in the United States: Behavioral Risk Factor Surveillance System, 2001. Prev Chronic Dis 2 (2005) A17
21. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, and The President's Council on Physical Fitness and Sports. Physical Activity and Health: A Report of the Surgeon General (1996), Office of the Surgeon General, Washington, DC
22. Centers for Disease Control and Prevention, Division of Nutrition and Physical Activity. Physical activity recommendations (2005). http://www.cdc.gov/nccdphp/dnpa/physical/recommendations/index.htm Available at: http://www.cdc.gov/nccdphp/dnpa/physical/recommendations/index.htm. Accessed June 15
23. Therapeutic Research Faculty. Natural Medicines Comprehensive Database (2004). http://www.naturaldatabase.com Available at: http://www.naturaldatabase.com. Accessed August 18
24. US Department of Health and Human Services. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III Examination Data File. Public Use Data File Documentation No. 76200. Hyattsville, MD: Centers for Disease Control and Prevention; 1996.
25. Astrup A., and Toubro S. Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man. Int J Obes Relat Metab Disord 17 suppl 1 (1993) S41-S43
26. Preuss H.G., DiFerdinando D., Bagchi M., and Bagchi D. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: An overview. J Med 33 (2002) 247-264
27. Greenway F.L., De Jonge L., Blanchard D., Frisard M., and Smith S.R. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. Obes Res 12 (2004) 1152-1157
28. Fugh-Berman A., and Myers A. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: Current status of clinical and basic research. Exp Biol Med 229 (2004) 698-704
29. Haller C.A., Benowitz N.L., and Jacob III P. Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med 118 (2005) 998-1003
30. US Food and Drug Administration issues regulation prohibiting sale of dietary supplements containing ephedrine alkaloids and reiterates its advice that consumers stop using these products [press release]. Available at: http://www.cfsan.fda.gov/∼lrd/fpephed6.html. Accessed May 22, 2006.
31. US Food and Drug Administration. Final rule declaring ephedrine alkaloids adulterated because they present an unreasonable risk (2006). http://www.fda.gov/OHRMS/DOCKETS/98fr/1995n-0304-nfr0001.pdf Available at: http://www.fda.gov/OHRMS/DOCKETS/98fr/1995n-0304-nfr0001.pdf. Accessed May 22
32. American Heart Association. Cold and flu medication for people with high blood pressure (2006). http://www.americanheart.org/presenter.jhtml?identifier=580 Available at: http://www.americanheart.org/presenter.jhtml?identifier=580. Accessed July 13
33. American Academy of Family Physicians. Herbal products and supplements: What you should know (2006). http://familydoctor.org/860.xml Available at: http://familydoctor.org/860.xml. Accessed May 22
34. Position of The American Dietetic Association: Food and Nutrition Misinformation. J Am Diet Assoc 106 (2006) 601-607